Language selection

Government of Canada / Gouvernement du Canada

Search

Submissions received from stakeholders during the consultation period on the change to the definition of Gap medicines, the references to the comparator countries and the international price tests for Grandfathered medicines and their line extensions

  1. AbbVie Canada (PDF 252 KB)
  2. ALS Society of Canada (PDF 245 KB)
  3. ALS/SLA Action Canada (PDF 622 KB)
  4. Amgen Canada Inc. (PDF 524 KB)
  5. Association des bannières et des chaînes de pharmacies du Québec (ABCPQ) (PDF 73 KB)[available in French only]
  6. Association québécoise des distributeurs en pharmacie (AQDP) (PDF 296 KB)[available in French only]
  7. Association québécoise des pharmaciens propriétaires (AQPP) (PDF 182 KB)[available in French only]
  8. Astellas Pharma Canada, Inc. (PDF 629 KB)
  9. AstraZeneca Canada Inc. (PDF 223 KB)
  10. Bayer Inc. (PDF 213 KB)
  11. BC Ministry of Health, Pharmaceutical, Laboratory and Blood Services Division (PDF 133 KB)
  12. Best Medicines Coalition (PDF 242 KB)
  13. BioAlberta (PDF 315 KB)
  14. BIOTECanada (PDF 130 KB)
  15. Boehringer Ingelheim (Canada) Ltd. (PDF 254 KB)
  16. Bristol Myers Squibb Canada  (PDF 161 KB)
  17. British Columbia Lung Association (PDF 1 MB)
  18. Canadian Association for Pharmacy Distribution Management (CAPDM) (PDF 156 KB)
  19. Canadian Cancer Society  (PDF 264 KB)
  20. Canadian Forum for Rare Disease Innovators (RAREi) (PDF 217 KB)
  21. Canadian Generic Pharmaceutical Association (CGPA) (PDF 159 KB)
  22. Canadian Health Research Forum (PDF 464 KB)
  23. Canadian Life and Health Insurance Association (CLHIA) (PDF 646 KB)
  24. Canadian Organization for Rare Disorders (CORD) (PDF 170 KB)
  25. Canadian Pharmacists Association (CPhA)  (PDF 174 KB)
  26. Canadian Union of Public Employees (CUPE) (PDF 298 KB)
  27. CONECTed (PDF 5.6 MB)
  28. Council of Senior Citizens Organizations of B.C. (COSCO) (PDF 139 KB)
  29. Cystic Fibrosis Canada (PDF 196 KB)
  30. Danish Life Sciences Forum (PDF 594 KB)
  31. Eisai Ltd. (PDF 247 KB)
  32. Eli Lilly Canada Inc.  (PDF 197 KB)
  33. Elvium Life Sciences (PDF 123 KB)
  34. EMD Serono Canada (PDF 212 KB)
  35. Gastrointestinal Society (PDF 252 KB)
  36. Gilead Sciences Canada, Inc. (PDF 364 KB)
  37. GlaxoSmithKline Inc.  (PDF 119 KB)
  38. Groupe Jean Coutu (Submission is confidential)
  39. Health Coalition of Alberta (PDF 228 KB)
  40. Hoffmann-La Roche Limited (PDF 94 KB)
  41. Innovative Medicines Canada (PDF 178 KB)
  42. Ipsen Biopharmaceuticals Canada Inc. (PDF 182 KB)
  43. Janssen Inc. (PDF 143 KB)
  44. LEO Pharma Inc. (PDF 127 KB)
  45. Life Sciences British Columbia (PDF 184 KB)
  46. Life Sciences Ontario (LSO) (PDF 182 KB)
  47. Lung Health Foundation (PDF 128 KB)
  48. McKesson Canada  (PDF 398 KB)
  49. Medicines Access Coalition – BC  (PDF 796 KB)
  50. Merck Canada Inc. (PDF 238KB)
  51. Multiple Sclerosis Society of Canada (PDF 99 KB)
  52. Neighbourhood Pharmacy Association of Canada (PDF 125 KB)
  53. Novartis Pharmaceuticals Canada Inc. (PDF 484 KB)
  54. PDCI Market Access Inc.  (PDF 198 KB)
  55. Pfizer Canada ULC (PDF 571 KB)
  56. Sanofi Canada (PDF 30 KB)
  57. Santen Canada Inc. (PDF 54 KB)
  58. Servier Canada Inc. (PDF 198 KB)
  59. Shoppers Drug Mart and Loblaws Pharmacies (PDF 261 KB)
  60. Sunovion Pharmaceuticals Canada Inc. (PDF 831 KB)
  61. Takeda Canada Inc.  (PDF 160 KB)
  62. Ultragenyx Canada Inc. (PDF 1 MB)
  63. Vaccine Industry Committee (PDF 183 KB)
  64. Valeo Pharma Inc. (PDF 1 MB)
  65. Vertex Pharmaceuticals (Canada) Inc. (PDF 196 KB)
  66. VIATRISTM Canada (PDF 219 KB)

Page details

Date modified: